Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 9Sarcoma 6Genitourinary 5Other solid neoplasm 3Gynecologic 3Lymphoid 2Gastrointestinal 2Head & Neck 1Dermatologic 1Classical hematology 1

Conditions

Head and Neck Neoplasms 15Squamous Cell Carcinoma of Head and Neck 8Esthesioneuroblastoma, Olfactory 5Sarcoma 4Ovarian Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Small Cell Lung Carcinoma 3Salivary Gland Neoplasms 3Osteosarcoma 3Lung Neoplasms 3Kidney Neoplasms 3Chondrosarcoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma, Kaposi 2Oligodendroglioma 2Neuroblastoma 2Neoplasms, Unknown Primary 2Nasopharyngeal Neoplasms 2Melanoma 2Medulloblastoma 2Lymphoma 2Carcinoma, Ovarian Epithelial 2Astrocytoma 2AIDS-related Kaposi sarcoma 2

Interventions

Oxaliplatin 2Temozolomide 1Tamoxifen 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Irinotecan 1Filgrastim 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × Filgrastim × Head & Neck × Clear all
NCT00005952 2013-06-20

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Duke University

Phase 1/2 Completed
30 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Testicular Germ Cell Tumor, Astrocytoma, Head and Neck Neoplasms, Kidney Neoplasms, Medulloblastoma, Nasopharyngeal Neoplasms, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡